CD276 and head and neck squamous cell carcinoma: Considering the prognostic relevance of the other immune checkpoints ligands for this cohort, CD276 (B7-H3) was one of the main immune checkpoint ligands as potentially interesting for HNSCC, identified by both our in silico and immunohistochemical observations.